Loading...
XJPX
4483
Market cap1.27bUSD
Jul 10, Last price  
3,170.00JPY
1D
0.63%
1Q
-10.20%
IPO
68.84%
Name

JMDC Inc

Chart & Performance

D1W1MN
XJPX:4483 chart
P/E
30.67
P/S
4.11
EPS
103.37
Div Yield, %
0.51%
Shrs. gr., 5y
3.00%
Rev. gr., 5y
24.65%
Revenues
50.46b
+20.95%
3,022,000,00010,064,000,00012,158,000,00016,771,000,00021,814,000,00027,809,000,00030,572,000,00041,722,000,00050,462,000,000
Net income
6.77b
+13.49%
390,000,0001,010,000,0001,528,000,0002,476,000,0003,247,000,0004,268,000,0003,321,000,0005,961,000,0006,765,000,000
CFO
8.59b
-41.48%
978,000,0001,756,000,0003,146,000,0003,176,000,0003,808,000,0004,062,000,000-17,000,00014,685,000,0008,594,000,000
Dividend
Mar 28, 202516 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.
IPO date
Dec 16, 2019
Employees
1,315
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT